The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Valeant Pharmaceuticals to Present at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference

Friday, April 27, 2012

Valeant Pharmaceuticals to Present at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference09:00 EDT Friday, April 27, 2012MONTREAL, April 27, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the Deutsche Bank Securities, Inc. 37th Annual Health Care Conference on Monday, May 7, 2012 at 2:50 p.m. ET. The conference will be held at the InterContinental Hotel in Boston.A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast can also be accessed through the following URL: http://www.media-server.com/m/p/4c46bofrAbout Valeant Valeant Pharmaceuticals International, Inc. (NYSE:VRX/TSX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at www.valeant.com.(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO) Contact:Laurie LittleValeant Pharmaceuticals949-461-6002SOURCE Valeant Pharmaceuticals International, Inc.